EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Therapeutic Plasma Exchange in the Elderly: Rare Indications but Good Tolerability

Valentin Coirier iD, Quentin Quelven, Pauline Guillot, Elie Jalaber, Floriane L'Her, Vincent Joussellin iD, Félicie Bélicard, Kieran Pinceaux iD, Adel Maamar, Mathieu Lesouhaitier, Jean-Marc Tadié, Nicolas Terzi

Journal of Clinical Apheresis · 2026-06 · 41 (3)

DOI: 10.1002/jca.70155 ↗

At a glance

Journal article in Journal of Clinical Apheresis, published online on 2026-06-22. Written by Valentin Coirier and 11 co-authors. Institution: Médecine Intensive-Réanimation, CHU de Rennes, Rennes, France. Major MEDLINE topics: Plasma Exchange. 32 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Therapeutic plasma exchange (TPE) is used for a wide range of indications and is associated with well‐described adverse events. However, no study has specifically focused on tolerance in elderly patients, despite its expected increasing use in this population. We conducted a single‐center retrospective case–control study of all patients aged ≥ 75 years who underwent TPE between 2011 and 2023. Adverse events were identified through standardized surveillance forms completed contemporaneously. The primary outcome was the rate of any adverse event occurring during TPE sessions, compared between patients aged ≥ 75 years (elderly group) and those < 75 years. Elderly patients accounted for 7.4% of all TPE sessions during the study period. Thirty‐one patients were included in each group, corresponding to 506 TPE sessions. Hypertension and cardiac disease were significantly more frequent in the elderly group. Overall adverse event rates were similar in the two groups (40.6% in < 75 years vs. 43.4% in ≥ 75 years, p = 0.592). Asymptomatic hypocalcemia was more frequent in elderly patients, whereas allergic reactions were more frequent in younger patients. One‐year survival did not differ between groups ( p = 0.31). TPE in patients aged ≥ 75 years is uncommon, but its tolerance is comparable to that of younger patients. When clinically indicated, TPE should not be withheld on the basis of age alone.

Subjects

MeSH terms (MEDLINE)

Plasma ExchangeHumansAgedRetrospective StudiesFemaleCase-Control StudiesMaleAged, 80 and overHypocalcemiaAge FactorsHypertension

Author keywords

adverse eventelderlytherapeutic plasma exchange

Authors and institutions

  • Médecine Intensive-Réanimation, CHU de Rennes, Rennes, France.
  • Faculté de Médecine, Université de Rennes 1, Rennes, France.

ORCID profiles: Valentin Coirier, Vincent Joussellin, Kieran Pinceaux

Cite

APA

Coirier, V., Quelven, Q., Guillot, P., Jalaber, E., L'Her, F., Joussellin, V., Bélicard, F., Pinceaux, K., Maamar, A., Lesouhaitier, M., Tadié, J. M., & Terzi, N. (2026). Therapeutic Plasma Exchange in the Elderly: Rare Indications but Good Tolerability. Journal of Clinical Apheresis, 41(3). https://doi.org/10.1002/jca.70155

Vancouver

Coirier V, Quelven Q, Guillot P, Jalaber E, L'Her F, Joussellin V, et al. Therapeutic Plasma Exchange in the Elderly: Rare Indications but Good Tolerability. Journal of Clinical Apheresis. 2026;41(3). doi:10.1002/jca.70155

BibTeX
@article{Coirier2026,
  author = {Coirier, Valentin and Quelven, Quentin and Guillot, Pauline and Jalaber, Elie and L'Her, Floriane and Joussellin, Vincent and Bélicard, Félicie and Pinceaux, Kieran and Maamar, Adel and Lesouhaitier, Mathieu and Tadié, Jean-Marc and Terzi, Nicolas},
  title = {Therapeutic Plasma Exchange in the Elderly: Rare Indications but Good Tolerability},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  volume = {41},
  number = {3},
  doi = {10.1002/jca.70155}
}
Start for free →